At close: June 14 at 4:00 PM EDT
After hours: June 14 at 7:32 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 19 | 19 |
| Avg. Estimate | 1.86 | 1.92 | 7.29 | 8.09 |
| Low Estimate | 1.78 | 1.83 | 6.74 | 7.41 |
| High Estimate | 1.94 | 2.01 | 8.41 | 9.4 |
| Year Ago EPS | 1.83 | 1.83 | 6.9 | 7.29 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 5 | 18 | 18 |
| Avg. Estimate | 12.28B | 12.48B | 49.25B | 51.57B |
| Low Estimate | 12.07B | 12.24B | 47.54B | 48.73B |
| High Estimate | 12.45B | 12.77B | 50.41B | 53.88B |
| Year Ago Sales | 13.62B | 11.78B | 45.44B | 49.25B |
| Sales Growth (year/est) | -9.80% | 5.90% | 8.40% | 4.70% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 1.68 | 1.7 | 1.68 | 1.69 |
| EPS Actual | 1.83 | 1.83 | 1.53 | 1.8 |
| Difference | 0.15 | 0.13 | -0.15 | 0.11 |
| Surprise % | 8.90% | 7.60% | -8.90% | 6.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.86 | 1.92 | 7.29 | 8.09 |
| 7 Days Ago | 1.86 | 1.92 | 7.28 | 8.09 |
| 30 Days Ago | 1.85 | 1.91 | 7.27 | 8.03 |
| 60 Days Ago | 1.81 | 1.86 | 7.12 | 7.85 |
| 90 Days Ago | 1.81 | 1.85 | 7.15 | 7.89 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 4 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NVS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 1.60% | -- | -- | 8.40% |
| Next Qtr. | 4.90% | -- | -- | 11.00% |
| Current Year | 5.70% | -- | -- | 5.10% |
| Next Year | 11.00% | -- | -- | 12.10% |
| Next 5 Years (per annum) | 10.51% | -- | -- | 11.36% |
| Past 5 Years (per annum) | 6.08% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | BMO Capital: Market Perform to Market Perform | 4/24/2024 |
| Initiated | BMO Capital: Market Perform | 2/23/2024 |
| Initiated | Morgan Stanley: Equal-Weight | 1/23/2024 |
| Upgrade | Morgan Stanley: Underweight to Equal-Weight | 9/25/2023 |
| Downgrade | Wolfe Research: Outperform to Peer Perform | 5/9/2022 |
| Downgrade | Exane BNP Paribas: Outperform to Neutral | 12/6/2021 |
Related Tickers
AZN AstraZeneca PLC
79.59
+0.08%
SNY Sanofi
46.25
-2.69%
MRK Merck & Co., Inc.
129.48
+0.09%
GSK GSK plc
40.65
-1.12%
AMGN Amgen Inc.
298.62
+0.04%
BIIB Biogen Inc.
231.69
-0.92%
RHHBY Roche Holding AG
34.67
+0.41%
BMY Bristol-Myers Squibb Company
41.20
-0.68%
ABBV AbbVie Inc.
168.59
+1.22%
GILD Gilead Sciences, Inc.
65.06
+3.62%